Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An extremely rare and fatal central nervous system malformation occurring during embryogenesis, presenting prenatally with holoprosencephaly and fetal hypokinesia as major features. Other manifestations include microcephaly, multiple contractures and intrauterine growth restriction. An X-linked recessive inheritance has been suggested.
Features include: Microcephaly, Holoprosencephaly, Multiple joint contractures, and Decreased fetal movement and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Pregnancy and birth | 2 | Decreased fetal movement, Fetal akinesia sequence |
Head and neck |
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for holoprosencephaly-hypokinesia-congenital contractures syndrome.
300 publications have been identified in PubMed for holoprosencephaly-hypokinesia-congenital contractures syndrome. Kisho has analyzed 49 by research type. Research spans Review / Meta-Analysis (71%), Basic Science / Preclinical (14%), and Case Report / Case Series (6%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 35 | 71% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 11:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Microcephaly |
Bones and joints | 1 | Multiple joint contractures |
Muscles | 1 | Multiple joint contractures |
Growth and development | 1 | Intrauterine growth retardation |
Laboratory research |
7 |
14% |
Patient case studies | 3 | 6% |
Disease patterns and progression | 3 | 6% |
New treatment approaches | 1 | 2% |
Jimenez A (2026). [PMID: 32310590](https://pubmed.ncbi.nlm.nih.gov/32310590/). *Unknown Journal*. [Case Report / Case Series]
Jacob M (2026). [PMID: 40497796](https://pubmed.ncbi.nlm.nih.gov/40497796/). *Brain*. [Basic Science / Preclinical]
O'Shea G (2026). [PMID: 39811497](https://pubmed.ncbi.nlm.nih.gov/39811497/). *Plast Surg (Oakv)*. [Review / Meta-Analysis]
Debrach AC (2025). [PMID: 40241556](https://pubmed.ncbi.nlm.nih.gov/40241556/). *Rev Med Suisse*. [Review / Meta-Analysis]
Parra-Díaz P (2025). [PMID: 40048676](https://pubmed.ncbi.nlm.nih.gov/40048676/). *Neurology*. [Basic Science / Preclinical]
Agrawal R (2025). [PMID: 40200630](https://pubmed.ncbi.nlm.nih.gov/40200630/). *J Assoc Physicians India*. [Review / Meta-Analysis]
Liu Z (2025). [PMID: 40846989](https://pubmed.ncbi.nlm.nih.gov/40846989/). *Diabetol Metab Syndr*. [Epidemiology / Natural History]
Schubert T (2025). [PMID: 38950199](https://pubmed.ncbi.nlm.nih.gov/38950199/). *Dev Med Child Neurol*. [Review / Meta-Analysis]
Krusche M (2025). [PMID: 40960635](https://pubmed.ncbi.nlm.nih.gov/40960635/). *Z Rheumatol*. [Review / Meta-Analysis]
Yacoub MR (2025). [PMID: 40747632](https://pubmed.ncbi.nlm.nih.gov/40747632/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]